Kai Chen
Corporate Officer/Principal bij IOMAI CORPORATION
Profiel
Kai Chen is Vice President of Business Development for Iomai Corp.
Prior to joining Iomai, he was Chief of the Cancer and Biological Modifiers Branch of the NIH's Office of Technology Transfer.
Previously, he worked at MedImmune, Inc. Dr. Chen received a PhD in Biophysics from the University of Illinois and an MBA in Technology Management and Marketing from University of California, Los Angeles.
Actieve functies van Kai Chen
Bedrijven | Functie | Begin |
---|---|---|
IOMAI CORPORATION | Corporate Officer/Principal | - |
Eerdere bekende functies van Kai Chen
Bedrijven | Functie | Einde |
---|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
Opleiding van Kai Chen
University of Illinois | Doctorate Degree |
University of California, Los Angeles | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |